The treatment possibilities of patients with relapsed Hodgkin’s lymphoma, stages I and II: descriptive, retrospective study
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
693 9
Ultima descărcare din IBN:
2022-06-08 10:51
Căutarea după subiecte
similare conform CZU
616-006.441-036-08 (1)
Patologie. Medicină clinică (6852)
SM ISO690:2012
DĂNILĂ, Aliona. The treatment possibilities of patients with relapsed Hodgkin’s lymphoma, stages I and II: descriptive, retrospective study. In: Revista de Ştiinţe ale Sănătăţii din Moldova, 2018, nr. 3(17), pp. 52-60. ISSN 2345-1467.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Revista de Ştiinţe ale Sănătăţii din Moldova
Numărul 3(17) / 2018 / ISSN 2345-1467

The treatment possibilities of patients with relapsed Hodgkin’s lymphoma, stages I and II: descriptive, retrospective study

CZU: 616-006.441-036-08

Pag. 52-60

Dănilă Aliona
 
Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“
 
Disponibil în IBN: 15 decembrie 2018


Rezumat

Treatment of relapsed Hodgkin’s lymphoma in stages I-II after complete remission remains poorly effective (54.2%-68.0%) and life expectancy over 5 years is 80%.

Cuvinte-cheie
Hodgkin’s lymphoma, relapses, treatment.

DataCite XML Export

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'>
<creators>
<creator>
<creatorName>Dănilă, A.</creatorName>
<affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation>
</creator>
</creators>
<titles>
<title xml:lang='ro,en'>The treatment possibilities of patients with relapsed Hodgkin&rsquo;s lymphoma, stages I and II: descriptive, retrospective study</title>
</titles>
<publisher>Instrumentul Bibliometric National</publisher>
<publicationYear>2018</publicationYear>
<relatedIdentifier relatedIdentifierType='ISSN' relationType='IsPartOf'>2345-1467</relatedIdentifier>
<subjects>
<subject>Hodgkin’s lymphoma</subject>
<subject>relapses</subject>
<subject>treatment.</subject>
<subject schemeURI='http://udcdata.info/' subjectScheme='UDC'>616-006.441-036-08</subject>
</subjects>
<dates>
<date dateType='Issued'>2018-12-10</date>
</dates>
<resourceType resourceTypeGeneral='Text'>Journal article</resourceType>
<descriptions>
<description xml:lang='en' descriptionType='Abstract'><p>Treatment of relapsed Hodgkin&rsquo;s lymphoma in stages I-II after complete remission remains poorly effective (54.2%-68.0%) and life expectancy over 5 years is 80%.</p></description>
</descriptions>
<formats>
<format>application/pdf</format>
</formats>
</resource>